Edgen Stock·Sep 16 2025, 22:34戻る
戻る
Rigel Pharmaceuticals Raises 2025 Revenue Guidance Amid Strong Tavalisse Sales and Emerging Competition
Edgen Stock·Sep 16 2025, 22:34
[1] Can Tavalisse Drive Rigel's Growth Through the Rest of 2025? (https://finance.yahoo.com/news/tavalisse-driv ...)[2] Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update (https://vertexaisearch.cloud.google.com/groun ...)[3] 12 Affordable Biotech Stocks to Invest In Now - Insider Monkey (https://vertexaisearch.cloud.google.com/groun ...)